Quotient Sciences Recognized as a Winner of 2025 CDMO Leadership Awards
Read More41 - 45 of 157 results
In this article by the Medicine Maker, Richard Castledine discusses how to identify a safe, cost-efficient, and sustainable route to scalable API synthesis.The article explores the complexities of developing Active Pharmaceutical Ingredient...
Learn moreThis article by Drug Development & Delivery highlights the importance of Contract Development and Manufacturing Organizations (CDMOs) for the pharma and biotech companies when it comes to advancing innovative therapies. In ...
Learn more
In this article by the Medicine Maker, Asma Patel and John McDermott talk about the complexities of developing modified release formulations.These formulations allow more control over drug release in the gastrointestinal (GI) tract, providi...
Learn more
PHILADELPHIA, PA; June 5, 2024 – Quotient Sciences, the drug development and manufacturing accelerator, has announced changes to its operational leadership team for its Philadelphia, Pa. facilities. Marlene Leuenberger has joined as Vice Pr...
Learn moreThe article reflects on various interviews held during CPHI North America in Philadelphia. The event took place at the Philadelphia Convention Center from May 7th to 9th, 2024. Unlike its overseas counterparts, CPHI NA operates on ...
Learn more
